Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest epilepsy Stories

Protein Modification May Help Control Alzheimer's And Epilepsy
2013-06-03 19:41:06

American Friends of Tel Aviv University In the brain, cell-to-cell communication is dependent on neurotransmitters, chemicals that aid the transfer of information between neurons. Several proteins have the ability to modify the production of these chemicals by either increasing or decreasing their amount, or promoting or preventing their secretion. One example is tomosyn, which hinders the secretion of neurotransmitters in abnormal amounts. Dr. Boaz Barak of Tel Aviv University's Sagol...

2013-05-29 23:04:06

In response to the FDA´s Drug Safety Communications statement on May 6, 2013, Connecticut law firm Trantolo & Trantolo is accepting Depakote-related claims. Hartford, CT (PRWEB) May 29, 2013 Prescribed for seizure treatment since 1983, Depakote, in recent years, has been associated with birth defects and lower IQs when women take it during pregnancy, according to studies, both published in the New England Journal of Medicine, “Valproic Acid Monotherapy in Pregnancy and Major...

2013-05-28 21:28:40

A large scientific study has discovered new genes causing severe seizure disorders that begin in babies and early childhood. The finding will lead to new tests to diagnose these conditions and promises to lead to improved outcomes. Epileptic encephalopathies are severe seizure disorders occurring in infants and children. The seizures are accompanied by slow development and intellectual problems. Pediatric neurologist and researcher Professor Ingrid Scheffer from the University of...

2013-05-28 20:21:49

HOUSTON, May 28, 2013 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX) today announced the receipt of a letter from the Centers of Medicare and Medicaid Services (CMS) declining the company's request to reconsider the 2007 National Coverage Determination for the treatment-resistant depression indication. "Cyberonics is very disappointed in the position taken by CMS that the new evidence accumulated over the past five years and recently published in four peer-reviewed journals does...

2013-05-28 10:24:21

An epilepsy drug shows promise in an animal model at preventing tinnitus from developing after exposure to loud noise, according to a new study by researchers at the University of Pittsburgh School of Medicine. The findings, reported this week in the early online version of the Proceedings of the National Academy of Sciences, reveal for the first time the reason the chronic and sometimes debilitating condition occurs. An estimated 5 to 15 percent of Americans hear whistling, clicking,...

2013-05-28 08:29:34

HOUSTON, May 28, 2013 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the following conferences. Greg Browne, Cyberonics' Chief Financial Officer, will present at the Jefferies 2013 Global Healthcare Conference in New York on Thursday, June 6, 2013 at 9:00 AM Eastern Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link...

2013-05-27 23:14:13

In order to promote quality of life, the Northeast Regional Epilepsy Group (NEREG) is launching an epilepsy wellness program in New York and New Jersey for their adult patients diagnosed with epilepsy and seizures. New York, NY (PRWEB) May 27, 2013 Persons diagnosed with active epilepsy lose their driving privileges until seizure freedom is achieved. Public transportation or people who will volunteer to be a driver can be hard to find. As a result, independence becomes limited and it can be...

2013-05-24 23:26:56

Optimizing electrical stimulation to treat Parkinson's disease and other neurological conditions. Cleveland, OH and Durham, NC (PRWEB) May 23, 2013 NDI Medical, LLC, a venture and commercialization firm that funds and develops innovative neurodevice technologies, has launched its next portfolio company, Deep Brain Innovations, LLC (DBI). DBI will commercialize its groundbreaking technology that is designed to optimize deep brain stimulation (DBS) therapy for patients with Parkinson´s...

2013-05-20 16:26:32

Symptom improvements in-line with effects reported with stimulant drugs LOS ANGELES, May 20, 2013 /PRNewswire/ -- Today, at the American Psychiatric Association (APA) Meeting in San Francisco, James McGough, M.D., M.S., principal investigator and Professor of Clinical Psychiatry at the Semel Institute for Neuroscience and Human Behavior and David Geffen School of Medicine at the University of California Los Angeles (UCLA), and director of clinical teaching programs in both Child and...

2013-05-20 08:28:02

-- Warren Lammert, Investor and Father of Child with Epilepsy, Named Chairman -- LANDOVER, Md., May 20, 2013 /PRNewswire-USNewswire/ -- The Epilepsy Foundation, a national organization dedicated to serving all people with seizures, today announced the election of its first official Board of Directors, following the completion of its merger with the Epilepsy Therapy Project. Directors from both organizations and several new nominees sit on the newly-formed board. Warren Lammert,...